HIMS receives high rating from Validea's Quantitative Momentum Investor model.

From Nasdaq.: 2025-05-04 15:07:00

HIMS & HERS HEALTH INC (HIMS) receives a high rating from Validea’s Quantitative Momentum Investor model, based on Wesley Gray’s strategy. The stock, considered a mid-cap growth stock in the Biotechnology & Drugs industry, scores 83% based on fundamentals and valuation. The strategy looks for strong and consistent intermediate-term relative performance, with a score above 80% indicating interest and above 90% indicating strong interest. Analysis shows HIMS meets most criteria of the strategy, making it a potential investment option. Wesley Gray, an expert in quantitative investing strategies, is the founder of Alpha Architect and author of several books on investing.



Read more at Nasdaq.: Guru Fundamental Report for HIMS